- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
‘Bionic eye’ approved by FDA
U.S. regulators approved on Friday the use of a what’s being called a “bionic eye,” giving hope to those with a rare genetic disease that leads to gradual vision loss.
The Argus II Retinal Prosthesis System, developed by Second Sight Medical Products, Inc., is a first-of-its-kind retinal implant to treat those with advanced retinitis pigmentosa, or RP.
“While the [device] will not restore vision to patients, it may allow them to detect light and dark in the environment, aiding them in identifying the location or movement of objects or people,” the Food and Drug Administration said in a statement announcing approval of the technology.
The device, which is surgically implanted, includes a small camera with transmitter, both mounted on a pair of glasses the user wears. It also contains a video processing unit and retinal prosthesis that serves as the replacement for the cells that have degenerated in the retina.
It’s already been approved in Europe, Agence France-Presse reports.
“The device may help adults with RP who have lost the ability to perceive shapes and movement to be more mobile and to perform day-to-day activities,” said Jeffrey Shuren, director of FDA’s Center for Devices and Radiological Health.
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
About the Author
Cheryl Chumley is a continuous news writer for The Washington Times. Previously, she was part of the start-up team for The Washington Times’ digital aggregation product, Times247. She’s also a 2008-2009 Robert Novak journalism fellow with The Phillips Foundation. She can be reached at email@example.com.
- 'In Jesus name, we pray' sparks ire at Ohio council meeting
- Study: Barbie sours girls' career ambitions while Mrs. Potato Head busts gender roles
- Ted Turner hospitalized in S. America with possible appendicitis
- Obamacare fallout: 49 percent pessimistic; 45 percent 'scared'
- Russia accused of sinking own cruiser to block Ukrainian navy
Latest Blog Entries
TWT Video Picks
By Tammy Bruce
- Bill Clinton cashes in on struggling nonprofit hospital
- Putin has transformed Russian army into a lean, mean fighting machine
- BRUCE: Obama's bizarre immigration rules
- Kim Jong-un calls for execution of 33 Christians
- Bill Clinton poses for photo with Bunny Ranch prostitutes
- IRS to turn over Lerner emails in tea party targeting probe
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- Unemployment insurance vote could happen next week
- PRUDEN: Likening Putin to Hitler on Ukraine shows Hillary's shaky grasp of history
- DELAY: A revolution for the Constitution
Pope Francis meets his 'mini-me'
Celebrity deaths in 2014
Winter storm hits states — again